Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
**Financial Risk Summary: Caplin Point Laboratories Limited** Caplin Point faces a critical compliance exposure of ₹3–12 crore annually, driven by a maximum compliance risk score of 10/10 under SEBI BRSR mandates, with non-compliance risking enforcement action or delisting for a company of its ₹1,921 crore revenue scale. The company's undefined EPR (Extended Producer Responsibility) status—rated 6.5/10 exposure—creates material regulatory and financial uncertainty; unclear pharmaceutical packaging take-back obligations could trigger surprise compliance costs and operational disruptions under India's Plastic Waste Management Rules. While Scope 1 and 2 emissions reporting shows zero tCO2e (likely a data gap rather than actual decarbonization), the company must immediately clarify emissions inventory and GHG intensity baseline to satisfy SEBI BRSR Core Expansion disclosure requirements and avoid reputational or capital market penalties. Priority action: reconcile EPR applicability status and quantify true GHG/water intensity metrics within 6 months to de-risk the compliance risk rating.
Source: Caplin Point Laboratories Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.